Cargando…
Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis
OBJECTIVE: Receptor activator of NF-κβ ligand (RANKL) is crucial for the development of hepatic insulin resistance and poor glucose uptake; therefore, inhibiting RANKL with Denosumab could improve fasting plasma glucose (FPG) and insulin (FPI). METHODS: A systematic review was conducted to evaluate...
Autores principales: | Pacheco-Soto, Blanca T., Elguezabal-Rodelo, Rebeca Garazi, Porchia, Leonardo M., Torres-Rasgado, Enrique, Pérez-Fuentes, Ricardo, Gonzalez-Mejia, M. Elba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525927/ https://www.ncbi.nlm.nih.gov/pubmed/34676131 http://dx.doi.org/10.1080/21556660.2021.1989194 |
Ejemplares similares
-
Validation of a non-laboratorial questionnaire to identify Metabolic Syndrome among a population in central Mexico
por: Porchia, Leonardo M., et al.
Publicado: (2019) -
Differential effects of the methylenetetrahydrofolate reductase polymorphisms (C677T and A1298C) on hematological malignancies among Latinos: a meta-analysis
por: Garcia-Hernandez, Samanta Celeste, et al.
Publicado: (2019) -
Metallothionein-1 and nitric oxide expression are inversely
correlated in a murine model of Chagas disease
por: Gonzalez-Mejia, Martha Elba, et al.
Publicado: (2014) -
Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
por: Heinemann, Lutz, et al.
Publicado: (2018) -
A Prospective Study to Identify the Prevalence of Impaired Glucose Tolerance in Patients With Liver Cirrhosis Using Oral Glucose Tolerance Test
por: Reddy, Obul V, et al.
Publicado: (2023)